JPH0640828B2 - Crude drug manufacturing method - Google Patents

Crude drug manufacturing method

Info

Publication number
JPH0640828B2
JPH0640828B2 JP61055838A JP5583886A JPH0640828B2 JP H0640828 B2 JPH0640828 B2 JP H0640828B2 JP 61055838 A JP61055838 A JP 61055838A JP 5583886 A JP5583886 A JP 5583886A JP H0640828 B2 JPH0640828 B2 JP H0640828B2
Authority
JP
Japan
Prior art keywords
medium
crude drug
callus
culture
flax
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP61055838A
Other languages
Japanese (ja)
Other versions
JPS62210991A (en
Inventor
理 山田
匡 藤田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nisshin Oil Mills Ltd
Original Assignee
Nisshin Oil Mills Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nisshin Oil Mills Ltd filed Critical Nisshin Oil Mills Ltd
Priority to JP61055838A priority Critical patent/JPH0640828B2/en
Publication of JPS62210991A publication Critical patent/JPS62210991A/en
Publication of JPH0640828B2 publication Critical patent/JPH0640828B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Description

【発明の詳細な説明】 (a)産業上の利用分野 本発明はアマ(Linum )属の植物体の有する生薬成分を
総合的に活用するため、アマ属植物を組織培養し、得た
カルスを収獲して生薬として利用する方法に関する。
DETAILED DESCRIPTION OF THE INVENTION (a) Field of Industrial Application The present invention utilizes tissue-cultured flaxseed plants to obtain callus obtained by culturing flaxseed plants in order to comprehensively utilize crude drug components of plants belonging to the genus Linum. It relates to a method of harvesting and using it as a crude drug.

(b)従来の技術 アマ(Linum usitatissimum )及びその種子の亜麻仁
は、古来生薬として用いられてきた。即ち根は補虚,活
血薬に、茎や葉は鎮痛,止血薬に、また亜麻仁は皮膚の
かゆみ止めや養毛剤,胃腸薬,解毒鎮痛薬として用いら
れてきた(保育社「原色日本薬用植物図鑑」昭和58年
版)。
(b) Conventional Technology Flax (Linum usitatissimum) and its seed flaxseed have been used as ancient herbal medicines. That is, the root has been used as a complement, an active blood drug, the stems and leaves as an analgesic and a hemostatic agent, and the flax seed has been used as an anti-itch for skin and a hair-growth agent, a gastrointestinal drug, and an antidote analgesic agent. 1983 edition).

また亜麻仁のリン脂質は血清コレステロール値を下げる
作用が強く、動脈硬化症の予防にも有効である(特開昭
60−126224号)。
In addition, flaxseed phospholipids have a strong effect of lowering serum cholesterol level and are also effective in the prevention of arteriosclerosis (Japanese Patent Laid-Open Publication No. Sho.
60-126224).

さらに亜麻仁から得られるアマニ油は、我が国では塗料
などの工業用に用いられているが、欧米ではリノレン酸
を主な栄養源とする健康食品に使用されている。
In addition, flaxseed oil obtained from flaxseed is used for industrial purposes such as paints in Japan, but in Europe and the United States, it is used for health foods containing linolenic acid as a main nutrient source.

このように、アマは種子,茎,葉,根のすべてを健康食
品ないし生薬として活用でき、植物体全部を総合的に活
用することも可能である。
In this way, flax can utilize all of seeds, stems, leaves, and roots as a health food or a herbal medicine, and can also utilize the whole plant comprehensively.

(c)発明が解決しようとする問題点 しかるに現在アマはわが国ではほとんど栽培されず、ア
マニ油を採取するため種子が専ら輸入されている状況で
ある。しかし、輸入種子の亜麻仁から得る生薬は限られ
た工程からしか得られず、また根や生の茎,葉も入手し
にくい。
(c) Problems to be solved by the invention However, flax is rarely cultivated in Japan at present, and seeds are exclusively imported to collect linseed oil. However, crude drugs obtained from imported seed flaxseed can only be obtained through a limited process, and roots, raw stems and leaves are also difficult to obtain.

本発明は組織培養によって必要とする成分を含む培養物
を工場生産の規模で得る方法を提供せんとするもので、
この発明によればアマの任意の生薬成分を任意の時期に
得ることができる。即ち、根の有効成分,茎,葉の有効
成分或いは亜麻仁の有効成分を別々にでも総合的にでも
任意に得ることが可能となる。
The present invention is intended to provide a method for obtaining a culture containing a necessary component by tissue culture on a scale of factory production,
According to this invention, any crude drug component of flax can be obtained at any time. In other words, the active ingredient of root, the active ingredient of stem and leaf, or the active ingredient of flaxseed can be obtained separately or collectively.

なお、植物の組織培養によって生薬を作る方法としては
サイコ(特公昭56−52557 号)などの多くの発明がある
が、アマのカルスを培養し、その収獲物から生薬を製造
する方法は未だ知られていない。また、油脂生産植物を
組織培養してその培養物からトコフェロールを製造する
技術が大豆(特開昭59-154998 号)、ベニバナ(特開昭
60−149393号)などで知られているが、アマ属の植物の
組織培養による脂質成分の製造法は未だ知られていな
い。
In addition, there are many inventions such as Psycho (Japanese Patent Publication No. 56-52557) as a method for producing a crude drug by culturing plant tissue, but a method for culturing flax callus and producing a crude drug from the harvest is still unknown. Has not been done. Further, the technology for producing a tocopherol from a tissue culture of an oil and fat producing plant is soybean (Japanese Patent Laid-Open No. 59-154998), safflower (Japanese Patent Laid-Open No. Sho 59-154998).
No. 60-149393), etc., but a method for producing a lipid component by tissue culture of a flax plant has not yet been known.

(d)問題点を解決するための手段 即ち本発明は、アマ属植物を人工培地により組織培養
し、培養物を得ることを特徴とする生薬の製造法であ
る。さらに詳細には、アマ属植物の組織を、オーキシン
およびサイトカイニンを含有する人工培地で明または暗
培養してカルス細胞を形成させ、ついでこのカルス細
胞を成分濃度が1/2の前記人工培地で明培養して分化誘
導した不定芽となすか、あるいは前記カルス細胞を成
分濃度が1/2でかつオーキシンを含まない前記人工培地
で明培養して分化誘導した胚状体となし、このいずれか
から生薬成分を抽出することを特徴とする生薬の製造法
である。
(d) Means for Solving the Problem That is, the present invention is a method for producing a herbal medicine, which comprises culturing a flax plant in a tissue culture in an artificial medium to obtain a culture. More specifically, the tissue of a flax plant is light- or dark-cultured in an artificial medium containing auxin and cytokinin to form callus cells, and the callus cells are then exposed in the artificial medium having a component concentration of 1/2. Cultivated to differentiate into adventitious buds, or callus cells with a concentration of 1/2 and auxin-free in the artificial medium to produce differentiation-induced embryoid bodies, from which either A method for producing a crude drug, which comprises extracting a crude drug component.

本発明に用いるアマ属の植物としては Linum usitatiss
imum, Linum angustifoliumなどが挙げられるが、これ
らに限定されるものではない。
Linum usitatiss is a plant of the genus Flax used in the present invention.
Examples include imum and Linum angustifolium, but are not limited thereto.

ここでは通常、生薬として用いるアマを例として以下詳
細に説明する。
Here, the flax usually used as a crude drug will be described in detail below as an example.

アマ属のカルスを誘導するには一般的な公知の手法が適
用できる。即ち、アマの芽ばえや成長の旺盛な植物体の
組織切片、例えば葉,茎,茎頂,根,花の組織切片や種
子の胚のいずれを培養してもよいが、最も培養しやすい
芽ばえの葉,茎から組織切片を採ると作業性が良い。
A generally known method can be applied to induce callus of the genus Flax. In other words, tissue slices of flax seedlings and plants with strong growth, such as leaf, stem, shoot apex, root, flower tissue slices and seed embryos may be cultivated. Workability is good if tissue sections are taken from leaves and stems.

カルスの培養に用いる培地は一般的な無機塩類を基本と
した人工培地またはそれらの改変培地、例えばムラシゲ
・スクーグ(MS)の培地,ホワイトの培地,ヘラーの
培地,リンスマイヤー・スクーグ(LS)の培地,ニッ
チの培地,ハイポネックス培地などのいずれでもよく、
またこれらの培地に限定することなく公知のどの培地を
使用することもでき、それらの基本組成を適宜改変して
もよい。培地には、ビタミン類としてサイアミン塩酸
塩,ニコチン酸,ピリドキシン塩酸塩,イノシトール,
パントテン酸塩,ビオチンなど、糖としてグルコース,
蔗糖,ソルビトールなど、アミノ酸としてグリシン,ア
スパラギン,グルタミンなどの有機物を適宜添加し得
る。また、植物ホルモンとしてオーキシン類すなわち
2,4−D,インドール酢酸,インドール酪酸,ナフタ
レン酢酸などやサイトカイニン類即ちカイネチン,ベン
ジルアデニン,ゼアチンなどを適宜組み合わせて用い、
ココナツミルク,イーストエキス,モルトエキス,ペプ
トン,カゼイン分解物,バナナ汁など天然抽出物も適宜
加え得る。これらの培地は液体培地でも寒天を加え固体
培地でもよい。
The medium used for culturing callus is an artificial medium based on general inorganic salts or a modified medium thereof, such as Murashige-Skoog (MS) medium, White medium, Heller medium, and Rinsmeier-Skoog (LS) medium. Any of medium, niche medium, Hyponex medium, etc.,
Further, any known medium can be used without being limited to these media, and their basic composition may be appropriately modified. The medium contains vitamins such as thiamine hydrochloride, nicotinic acid, pyridoxine hydrochloride, inositol,
Glucose as sugar, such as pantothenate and biotin
Organic substances such as sucrose and sorbitol, such as glycine, asparagine, and glutamine, can be added as amino acids as appropriate. Further, auxins such as 2,4-D, indoleacetic acid, indolebutyric acid, and naphthaleneacetic acid as plant hormones, and cytokinins such as kinetin, benzyladenine, and zeatin are appropriately combined and used,
Natural extracts such as coconut milk, yeast extract, malt extract, peptone, casein degradation product, and banana juice may be added as appropriate. These media may be liquid media or solid media containing agar.

本発明における培養条件として温度は15〜30℃,p
H3.5〜8.5,暗または明条件で静置または振とう
培養のいずれも採用し得る。明条件は天然光でも人工光
でもよい。植継ぎは培養物の成長に合わせて1〜6週間
毎に行い、適宜分割する。
As the culture conditions in the present invention, the temperature is 15 to 30 ° C., p
H3.5-8.5, either static or shake culture in dark or light conditions can be adopted. The light condition may be natural light or artificial light. The subculture is performed every 1 to 6 weeks according to the growth of the culture, and divided appropriately.

十分増殖させた培養物は分化誘導培地に移して分化を促
進する。即ち、オーキシンの濃度を低下させカイネチン
を増加させたり、或いは植物成長ホルモンを除去した
り、塩濃度を低下させて、発根または発芽させ或いは胚
状体を形成させる。
The fully grown culture is transferred to a differentiation induction medium to promote differentiation. That is, the concentration of auxin is decreased to increase kinetin, or plant growth hormone is removed, or the salt concentration is decreased to cause rooting or germination or form embryoid bodies.

組織培養によって生薬成分を製造する際、カルスが未分
化で急速増殖期にあると、この時期のカルスに含まれる
生薬成分は希釈で、原植物体における含有有効成分より
低濃度である。しかし、カルスを分化誘導すると有効成
分が増加し、培養方法を工夫すると原植物体におけるよ
りも高濃度となる。本発明はアマ属植物のカルスを分化
誘導培地によって培養し、有効成分を高めて収獲するこ
とが好ましく、有効脂質やその他の全成分を総合的に得
たいときには胚状体(不定胚)、葉,茎の成分を多く得
たいときには不定芽、根の成分を多く得たいときには不
定根を夫々生ぜしめて収獲する。
When a callus is undifferentiated and is in a rapid growth phase when a crude drug component is produced by tissue culture, the crude drug component contained in the callus at this time is diluted and has a lower concentration than the active ingredient contained in the original plant. However, when callus is induced to differentiate, the active ingredient increases, and when the culture method is devised, the concentration becomes higher than in the original plant. In the present invention, it is preferable to culture callus of a flax plant with a differentiation-inducing medium to enhance and collect active ingredients, and when it is desired to comprehensively obtain effective lipids and all other ingredients, embryoid bodies (adventitious embryos), leaves , When you want to get a lot of stem components, adventitious buds, and when you want to get a lot of root components, grow adventitious roots.

(e)実施例 実施例1 a.カルス誘導 アマニ種子を一夜流水洗浄後70%エチルアルコール液
に短時間浸漬したのち、5%次亜塩素酸ナトリウム液に
20分間浸漬して滅菌し、滅菌水で洗い、この操作をも
う1度繰り返したのち、滅菌水で十分洗浄し、滅菌した
1%寒天液を固めた培養ピン上に滅菌種子を置床し、2
5℃4日間で発芽させ、更に5日間昼明所,夜暗所の条
件を与えて芽ばえ(2〜3cm)を得、これを無菌的に
0.5〜1cmの組織片とし、25℃暗所でMS培地(所
定無機塩類の他、イノシトール100,サイアミン塩酸
塩0.1,ニコチン酸0.5,ピリドキシン塩酸0.
5,クエン酸150各mg/、蔗糖30g/を添加
後pH6に調節し、寒天9g/を加え、2,4−D1
ppm,ベンジルアデニン0.2ppmを添加したも
の)に置床した。10日間でカルス化が観察され、1カ
月後には10〜15mmの大きさに成長した。カルスを
切離し、3週間毎に植継ぎ、2カ月後には生育の旺盛な
急速成長期のカルスを得た。
(e) Example Example 1 a. Callus induction After rinsing linseed seeds with running water overnight, immerse it in 70% ethyl alcohol solution for a short period of time, sterilize it by immersing it in 5% sodium hypochlorite solution for 20 minutes, wash with sterilized water, and repeat this operation again. After that, thoroughly wash with sterilized water, place the sterilized seeds on a culture pin in which sterilized 1% agar solution is solidified, and
Germinate at 5 ° C for 4 days, and then give seedlings (2 to 3 cm) under conditions of daylight and night darkness for 5 days to obtain 0.5 to 1 cm tissue pieces aseptically, and darken at 25 ° C. MS medium (in addition to predetermined inorganic salts, inositol 100, thiamine hydrochloride 0.1, nicotinic acid 0.5, pyridoxine hydrochloride 0.
5, citric acid 150 mg / each, sucrose 30 g / added, pH was adjusted to 6 and agar 9 g / added, 2,4-D1
ppm, 0.2 ppm of benzyladenine was added). Callus formation was observed in 10 days, and after 1 month, it grew to a size of 10 to 15 mm. The callus was cut off and replanted every 3 weeks, and after 2 months, callus in a rapid growth stage with vigorous growth was obtained.

b.分化誘導 このカルスを5〜10mmに分割し、濃度を1/2に下
げたMS培地に置床し、明培養して不定芽を得た。一方
1/2濃度のMS培地からオーキシンを除去した液体培
地で3週間毎に継代し、明培養することにより胚状体を
得た。更に、急速成長期のカルスを1/2濃度のMS
(オーキシンとしてナフタレン酢酸0.5ppm,サイ
トカイニンとしてベンジルアデニン0.1ppm)寒天
培地で3週間暗培養したのち、1/2濃度のMS脱ホル
モン液体培地で3週間毎に継代して暗培養した結果、発
根カルスを得た。
b. Induction of Differentiation This callus was divided into 5 to 10 mm, placed on MS medium whose concentration was reduced to 1/2, and subjected to light culture to obtain adventitious buds. On the other hand, the embryo medium was obtained by subculturing in a liquid medium obtained by removing auxin from a 1 / 2-concentration MS medium every 3 weeks and performing light culture. In addition, callus during the rapid growth phase
(Naphthalene acetic acid 0.5 ppm as auxin, benzyladenine 0.1 ppm as cytokinin) After dark culture for 3 weeks on agar medium, the result of dark culture by subculturing every 3 weeks on 1/2 concentration MS dehormonal liquid medium , Got rooted callus.

c.生薬効果 bで得た不定芽,胚状体,不定根の各カルスを収獲し、
培地成分を洗い流したのち、圧搾してジュースを得、そ
の生薬効果を比較し、表−1の結果を得た。
c. Crude drug effect Collect the adventitious bud, embryoid body and adventitious root callus obtained in b,
After washing away the medium components, it was squeezed to obtain juice, and the herbal drug effects were compared, and the results shown in Table 1 were obtained.

d.抽出成分 bで得た胚状体のリン脂質を表−2に示す。 d. Table 2 shows the phospholipids of the embryoid body obtained in Extraction Component b.

表−1,−2から培養物の成分はアマ植物の生薬成分と
ほぼ同等であることがわかる。
It can be seen from Tables 1 and 2 that the components of the culture are almost the same as the crude drug components of flax plants.

(f)発明の効果 本発明によればこれまで製造が困難であったアマの生薬
及びその成分を工場生産の規模で任意の時期に得ること
ができるとともに、人為的にアマの必要部位とくに葉,
茎および種子の生薬成分が任意に得られる。
(f) Effect of the Invention According to the present invention, it is possible to obtain a crude drug for flax and its components, which have been difficult to produce up to now, at any time on a scale of factory production, and artificially necessary parts of flax, especially leaves. ,
The crude drug components of stem and seed are optionally obtained.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.5 識別記号 庁内整理番号 FI 技術表示箇所 (C12P 9/00 C12R 1:91) ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 5 Identification number Office reference number FI technical display location (C12P 9/00 C12R 1:91)

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】アマ(Linum)属植物の組織を、オーキシ
ンおよびサイトカイニンを含有する人工培地で明または
暗培養してカルス細胞を形成させ、ついでこのカルス
細胞を成分濃度が1/2の前記人工培地で明培養して分化
誘導した不定芽となすか、あるいは前記カルス細胞を
成分濃度が1/2でかつオーキシンを含まない前記人工培
地で明培養して分化誘導した胚状体となし、このいずれ
かから生薬成分を抽出することを特徴とする生薬の製造
法。
1. A tissue of a plant belonging to the genus Linum is lightly or darkly cultured in an artificial medium containing auxin and cytokinin to form callus cells, and the callus cells are then artificially mixed at a component concentration of 1/2. To make an adventitious bud that is differentiation-induced by light culture in a medium, or to make an embryoid body that is differentiation-induced by light-culturing the callus cell in the artificial medium having a component concentration of 1/2 and no auxin, A method for producing a crude drug, which comprises extracting a crude drug component from any one of them.
JP61055838A 1986-03-12 1986-03-12 Crude drug manufacturing method Expired - Lifetime JPH0640828B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP61055838A JPH0640828B2 (en) 1986-03-12 1986-03-12 Crude drug manufacturing method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61055838A JPH0640828B2 (en) 1986-03-12 1986-03-12 Crude drug manufacturing method

Publications (2)

Publication Number Publication Date
JPS62210991A JPS62210991A (en) 1987-09-17
JPH0640828B2 true JPH0640828B2 (en) 1994-06-01

Family

ID=13010134

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61055838A Expired - Lifetime JPH0640828B2 (en) 1986-03-12 1986-03-12 Crude drug manufacturing method

Country Status (1)

Country Link
JP (1) JPH0640828B2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4831917A (en) * 1971-08-27 1973-04-26
JPS5652557A (en) * 1979-10-02 1981-05-11 Aisan Ind Co Ltd Air fuel ratio controller for carburetor

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4831917A (en) * 1971-08-27 1973-04-26
JPS5652557A (en) * 1979-10-02 1981-05-11 Aisan Ind Co Ltd Air fuel ratio controller for carburetor

Also Published As

Publication number Publication date
JPS62210991A (en) 1987-09-17

Similar Documents

Publication Publication Date Title
Sreekumar et al. Micropropagation of Hemidesmus indicus for cultivation and production of 2-hydroxy 4-methoxy benzaldehyde
KR101938835B1 (en) Method for vegetative propagation of Camellia japonica
Carra et al. Potential use of new diphenylurea derivatives in micropropagation of Capparis spinosa L.
Singh et al. Somatic embryogenesis and in vitro regeneration of an endangered medicinal plant sarpgandha (Rauvolfia serpentina L.)
CN113179951A (en) Rapid breeding method for tissue culture seedlings of cymbidium sinense
Shekhawat et al. An improved micropropagation protocol by ex vitro rooting of Passiflora edulis Sims. f. flavicarpa Deg. through nodal segment culture
KR100973839B1 (en) Method for mass propagation of callus and method for mass division of Iris odaesanensis flower utilizing leaf segments of Iris odaesanensis
CN114097611B (en) Low-cost method for breeding cymbidium maculatum tissue culture seedlings
KR20120000832A (en) Proliferation method of pro-embryogenic in yellow poplar
Mridula et al. In vitro organogenesis from Tinospora cordifolia (Willd.) Miers—a highly valuable medicinal plant
US20040203151A1 (en) Efficient method of in-vitro micropropagation of piper longum
Bhatia et al. Development of a rapid method for micropropagation of a new pineapple [Ananas comosus (l.) Murr.] clone,'Yeppoon gold'
Agnihotri et al. In vitro cloning of female and male Carica papaya through tips of shoots and inflorescences
CN106134987A (en) Exocarpium Citri Rubrum tissue-culturing quick-propagation and method for culturing seedlings
CN107439211B (en) Method for shortening eggplant germination time
Vibhute et al. Comparison of in vitro plantlet regeneration aptitude of three citrus species from cultured nodal segments via organogenic mode. Eco
Khan et al. Establishment of in vitro regeneration protocol for Adhatoda vasica Nees
Arumugam et al. Micro propagation and tissue culture of the endangered medicinal plant Withania somnifera by the direct shoot and root initiation method
US7485462B2 (en) Commercially viable process for in-vitro mass culture of Chlorophytum borivilianum
Mirniam et al. A novel protocol for Stevia rebaudiana Bert regeneration
JPH0640828B2 (en) Crude drug manufacturing method
KR101971978B1 (en) Method for vegetative propagation of Chaenomeles sinensis using somatic embryo induction and plant regeneration
CN111771729A (en) Tissue culture and rapid propagation method for pitaya
Amany et al. In vitro propagation of jackfruit (Artocarpus heterophyllus L.)
FR2510354A1 (en) PROCESS FOR THE PREPARATION OF THE PROPAGATION MATERIAL OF DIGITAL (DIGITALIS LANATA EHRH.) IN A CULTURE OF TISSUE